Page last updated: 2024-10-27

foscarnet and ATLL

foscarnet has been researched along with ATLL in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holida, MD1
Trigg, ME1
Rumelhart, SL1
Lee, NF1
Kook, H1
Peters, C1
Takimoto, Y1

Other Studies

2 other studies available for foscarnet and ATLL

ArticleYear
Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy.
    AIDS (London, England), 1995, Volume: 9, Issue:5

    Topics: Bone Marrow Transplantation; Child, Preschool; Cytomegalovirus Infections; Cytomegalovirus Retinitis

1995
Improvement of adult T-cell lymphoma/leukaemia by antiviral drugs including foscarnet.
    British journal of haematology, 1998, Volume: 102, Issue:3

    Topics: Adult; Antiviral Agents; Foscarnet; Humans; Leukemia-Lymphoma, Adult T-Cell; Male

1998